Loading...

4,068 posters, 219 videos, 101 topics, 69 sessions, 14,365 authors, 6,128 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

Alzheimer's Association International Conference 2026

July 12-15, 2026 | London, United Kingdom, and Online

Alzheimer's Association International Conference 2026 banner

4869

Mood Symptoms In Cognitively Unimpaired Older Adults And Their Informants: Effects On Complaints And Agreement In Dyadic Reporting

Part of Topic

Mood symptoms in cognitively unimpaired older adults and their informants: effects on cognitive complaints and agreement in dyadic reporting

Lucía Pérez-Blanco, PhD¹,², Sonali Arora, MSc¹,²,³, Eduardo Picón, PhD⁴, Sabela C. Mallo, PhD¹,²,³, Ana Nieto-Vieites, PhD¹,², María Campos-Magdaleno, PhD¹,²,³, Cristina Lojo-Seoane, PhD¹,²,³, Arturo X. Pereiro, PhD¹,²,³

¹ Applied Cognitive Neuroscience and Psychogerontology Group, Health Research Institute of Santiago (IDIS), Spain
² Department of Developmental Psychology, Faculty of Psychology, Universidade de Santiago de Compostela, Santiago de Compostela, Spain
³ Instituto de Psicoloxía (IPsiUS), Universidade de Santiago de Compostela, Spain
⁴ Methodology of Behavioral Sciences, Faculty of Psychology, Universidade de Santiago de Compostela, Spain

Contact: sonali.arora1@usc.es

Alzheimer’s Association International Conference | July 12–15, 2026 | London, UK

BACKGROUND

The influence of mood symptoms on self- or informant-reported subjective cognitive complaints (SCC) in the preclinical stages of dementia remains unclear (Nosheny et al., 2022).

Our objective was to investigate whether depressive and anxiety symptoms in participants without objective cognitive impairment and their informants may affect the severity of complaints and the agreement in dyadic reporting.

METHODS

291 participants, 75.94% women, and their informants, 60% women, from the Compostela Aging Study were included.

The Memory Failures of Everyday questionnaire (MFE; Sunderland et al., 1984) was administered to participants and informants to assess the severity of SCC.

“Dyadic SCC” was categorized based on established MFE cut-off points (Pérez-Blanco et al., 2025) into four groups:

  1. Agreement on absence
    Both scores low
    Participant score < 12.5
    Informant score < 9.5

  2. Agreement on presence
    Both scores above cut-off
    Participant score ≥ 12.5
    Informant score ≥ 9.5

  3. Self-over-reporting
    Participant above cut-off and informant below cut-off
    Participant score ≥ 12.5
    Informant score < 9.5

  4. Informant-over-reporting
    Participant below cut-off and informant above cut-off
    Participant score < 12.5
    Informant score ≥ 9.5

The Generalized Anxiety Disorder scale (GAD-7; Spitzer et al., 2006) and the Geriatric Depression Scale (GDS-15; Sheikh & Yesavage, 1986) were used to evaluate anxiety and depressive symptoms, respectively.

Informants completed the Goldberg Anxiety and Depression Scale (GADS; Goldberg et al., 1988).

We conducted a multinomial logistic regression with “Dyadic SCC” as the dependent variable. Predictors were total anxiety and depression scores, adjusted for sex, age, and Charlson Comorbidity Index (CCI).

RESULTS

Participant MFE score positively correlated with GDS-15, GAD-7, and informant MFE score, whereas informant-reported MFE score significantly correlated with GADS-Anxiety, GADS-Depression subscales, and GDS-15.

Table 1. Spearman correlations

MFE participant and GDS-15 participant: .397**
MFE participant and GAD-7 participant: .272**
MFE participant and MFE informant: .294**
MFE participant and GADS-Anxiety informant: -.063
MFE participant and GADS-Depression informant: -.004

GDS-15 participant and GAD-7 participant: .551**
GDS-15 participant and MFE informant: .190**
GDS-15 participant and GADS-Anxiety informant: .146*
GDS-15 participant and GADS-Depression informant: .024

GAD-7 participant and MFE informant: .091
GAD-7 participant and GADS-Anxiety informant: .128*
GAD-7 participant and GADS-Depression informant: .003

MFE informant and GADS-Anxiety informant: .244**
MFE informant and GADS-Depression informant: .185**

GADS-Anxiety informant and GADS-Depression informant: .614**

Note: *p < .05; **p < .001.
MFE = Memory Failures of Everyday Questionnaire; pt = participant; GDS-15 = Geriatric Depression Scale; GAD-7 = Generalized Anxiety Disorder Scale; inf = informant; GADS-Anxiety = Goldberg anxiety subscale; GADS-Depression = Goldberg depression subscale.

Regression analysis

The regression model was statistically significant:
χ²(18, N = 291) = 99.776, p < .001

The model showed an acceptable fit:
Nagelkerke R² = .313
McFadden R² = .130

Table 2. Regression analysis summary

Reference category: Agreement on absence

Agreement on presence

Intercept:
B = -6.052; SE = 1.360; Wald = 19.804; p < .001

GAD-7 participant:
B = .008; SE = .039; Wald = .039; p = .844; OR = 1.008; 95% CI [.933, 1.089]

GADS-Anxiety informant:
B = -.061; SE = .087; Wald = .493; p = .483; OR = .941; 95% CI [.794, 1.115]

GDS-15 participant:
B = .311; SE = .073; Wald = 18.157; p < .001**; OR = 1.365; 95% CI [1.183, 1.575]

GADS-Depression informant:
B = .214; SE = .113; Wald = 3.576; p = .059; OR = 1.239; 95% CI [.992, 1.548]

Age participant:
B = .066; SE = .020; Wald = 11.121; p < .001**; OR = 1.068; 95% CI [1.028, 1.111]

Sex participant, male reference:
B = .183; SE = .395; Wald = .214; p = .643; OR = 1.200; 95% CI [.554, 2.602]

CCI participant:
B = .032; SE = .271; Wald = .014; p = .906; OR = 1.032; 95% CI [.607, 1.757]

Self-over-reporting

Intercept:
B = -1.293; SE = 1.301; Wald = 2.186; p = .139

GAD-7 participant:
B = -.023; SE = .041; Wald = .330; p = .566; OR = .977; 95% CI [.902, 1.058]

GADS-Anxiety informant:
B = -.295; SE = .100; Wald = 8.623; p = .003*; OR = .745; 95% CI [.612, .907]

GDS-15 participant:
B = .323; SE = .074; Wald = 19.134; p < .001**; OR = 1.381; 95% CI [1.195, 1.595]

GADS-Depression informant:
B = .147; SE = .135; Wald = 1.184; p = .277; OR = 1.158; 95% CI [.889, 1.508]

Age participant:
B = .020; SE = .020; Wald = 1.019; p = .313; OR = 1.020; 95% CI [.981, 1.061]

Sex participant, male reference:
B = -.442; SE = .445; Wald = .988; p = .320; OR = .643; 95% CI [.269, 1.537]

CCI participant:
B = -1.057; SE = .441; Wald = 5.752; p = .016*; OR = .347; 95% CI [.146, .824]

Informant-over-reporting

Intercept:
B = -6.384; SE = 1.673; Wald = 14.565; p < .001

GAD-7 participant:
B = -.101; SE = .058; Wald = 3.059; p = .080; OR = .904; 95% CI [.807, 1.012]

GADS-Anxiety informant:
B = .146; SE = .100; Wald = 2.100; p = .147; OR = 1.157; 95% CI [.950, 1.409]

GDS-15 participant:
B = .143; SE = .095; Wald = 2.260; p = .133; OR = 1.154; 95% CI [.957, 1.390]

GADS-Depression informant:
B = .103; SE = .133; Wald = .593; p = .441; OR = 1.108; 95% CI [.853, 1.439]

Age participant:
B = .070; SE = .024; Wald = 8.349; p = .004*; OR = 1.073; 95% CI [1.023, 1.125]

Sex participant, male reference:
B = -.256; SE = .481; Wald = .283; p = .595; OR = .774; 95% CI [.301, 1.988]

CCI participant:
B = .213; SE = .302; Wald = .498; p = .480; OR = 1.237; 95% CI [.685, 2.234]

Note: OR = Odds Ratio; GAD-7 = Generalized Anxiety Disorder Scale; pt = participant; GADS-Anxiety = Goldberg anxiety subscale; inf = informant; GDS-15 = Geriatric Depression Scale; GADS-Depression = Goldberg depression subscale; CCI = Charlson Comorbidity Index.
*p < .005; **p < .001.

MAIN FINDINGS

Higher self-reported depressive symptoms increased the likelihood of “Agreement on presence” and “Self-over-reporting” compared with “Agreement on absence”.

“Self-over-reporting” was associated with greater comorbidity in participants and lower informant-level anxiety.

For “Informant-over-reporting”, the only significant predictor was participant age.

CONCLUSIONS

Depressive symptoms emerged as the most consistent predictor of high severity of self-expressed complaints.

No apparent association was found between the informant’s mood and the severity of informant-reported complaints.

REFERENCES

Nosheny et al. (2022). The role of dyadic cognitive report and subjective cognitive decline in early ADRD clinical research and trials: Current knowledge, gaps, and recommendations. Alzheimer’s & Dementia.

Spitzer, R. L., et al. (2006). A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of Internal Medicine.

Yesavage, J. A., & Sheikh, J. I. (1986). Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. Clinical Gerontologist.

Pérez-Blanco, L., et al. (2025). Discrimination between stability and worsening in participants without objective cognitive impairment using Memory Failures of Everyday (MFE) questionnaire total scores: Comparison of self- and informant-reports. Alzheimer’s & Dementia.

Goldberg, D., et al. (1988). Detecting anxiety and depression in general medical settings. BMJ.

Sunderland et al. (1984). Memory failures in everyday life following severe head injury. Journal of Clinical Neuropsychology.

Comments

Email is required but is not shown publicly.

Loading comments...

aaic2026 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.